Alan Craig Townsley, Ph.D. Student Associate

Dr. Townsley is a student associate at Sughrue Mion and works out of the Washington office. His practice focuses on worldwide procurement of patents in the biotechnology, chemical and pharmaceutical industries.

U.S. Patent and Trademark Office

George Washington University Law School (J.D.  2013)
National Institutes of Health (Postdoctoral Fellow Laboratory of Dr. Bernard Moss ; Laboratory of Viral Diseases, Bethesda, MD; 2004-2007)
The University of Edinburgh, United Kingdom (Ph.D. Laboratory of Clinical and Molecular Virology Center for Infectious Diseases, 2004)
The University of Edinburgh, United Kingdom (B.S. Department of Medical Microbiology, Faculty of Medicine, 2000)

NIH FELCOM Fellows Award for Research Excellence (2006)
National Institutes of Health Visiting Postdoctoral Fellowship (2004 - 2007)
Biotechnology and Biological Sciences Research Council Ph.D. Scholarship (2000 - 2003)


Associations
American Society for Virology
Society for General Microbiology

• Coauthor, Vaccinia virus strain differences in cell attachment and entry, Virology, 2009; 389:132-40.
• Townsley et al., Two distinct low-pH steps promote entry of vaccinia virus. J Virol., 2007; 81(16):8613-20.
• Townsley et al., Vaccinia virus entry into cells via a low-pH-dependent endosomal pathway. J Virol., 2006; 80(18):8899-908.
• Coauthor, Poxvirus multiprotein entry-fusion complex. Proc Natl Acad Sci U S A., 2005; 102(51):18572-7.
• Townsley et al., The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion. J Virol., 2005; 79(17):10988-98.
• Townsley et al., Vaccinia virus A21 virion membrane protein is required for cell entry and fusion. J Virol., 2005; 79(15):9458-69.
• Townsley et al. The m4 gene of murine gammaherpesvirus modulates productive and latent infection in vivo. J Virol., 2004; 78(2):758-67.
• Coauthor, Diversity of Tn1546 elements in clinical isolates of glycopeptide-resistant enterococci from Scottish hospitals. Antimicrob Agents Chemother., 2001; 45(4):1309-11.